Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
01/05/2005 | CN1559502A Chinese medicinal composition for treating sexual dysfunction |
01/05/2005 | CN1559497A Chinese medicine tighten ointment for treating vagina laxation |
01/05/2005 | CN1559490A Medicine capsule for treating male infertility |
01/05/2005 | CN1559483A Medicinal preparation for treating aphoria |
01/05/2005 | CN1559406A Series medicine prepn. contg. tinidazole used as compound for anti-trichomoniasis and anti-anaerobic former |
01/05/2005 | CN1183247C Membrane destroyed freeze-bried spermatozoa or sperm head and its making method |
01/05/2005 | CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands |
01/05/2005 | CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof |
01/05/2005 | CN1182856C External medicine for treating mastopathy and its prepn process |
01/04/2005 | US6838584 Estrogen receptor modulators |
01/04/2005 | US6838476 Imidazoles with anti-inflammatory activity |
01/04/2005 | US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones |
01/04/2005 | US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
01/04/2005 | US6838456 Condensed pyridoindole derivatives |
01/04/2005 | US6838442 Administering to said subject a jointly effective amount of a glucose reabsorption inhibitor; administering jointly effective amount of an retinoid-X receptor modulator for therapy of diabetes or Syndrome X |
01/04/2005 | CA2301503C Pharmaceutical compositions for oral administration of molecular iodine |
12/30/2004 | US20040267028 Such as 2-amino-1-(2-chlorophenyl)-5-(4-chlorophenyl)-N-cyclohexyl-1H-pyrrole-3-carboxamide hydrochloride |
12/30/2004 | US20040267010 For therapy of central nervous system disorders |
12/30/2004 | US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
12/30/2004 | US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders |
12/30/2004 | US20040266812 (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione |
12/30/2004 | US20040266773 Such as 4-(3-methoxyphenyl)-5-methyl-6-(2-fluorobenzyl)-2-(N-(2-pyridyl)ethyl-N -methyl)ethyl-pyridazin-3-one; drugs/prodrugs for treatment of sex-hormone related conditions in men/women |
12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
12/30/2004 | US20040266765 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
12/30/2004 | US20040266745 Estrogen-gestagen combination preparations and uses thereof |
12/30/2004 | US20040266678 Methods and compositions for treating polycystic ovary syndrome |
12/30/2004 | US20040266025 Screening and treatment methods for prevention of preterm delivery |
12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
12/30/2004 | US20040265399 plant extracts used for prevention or treatment of lesions caused by estrogen deficiency |
12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
12/30/2004 | US20040265380 Orodispersible effervescent tablets |
12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
12/29/2004 | WO2004113381A1 Relaxin superfamily peptide analogues |
12/29/2004 | WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same |
12/29/2004 | WO2004113300A1 Novel tricyclic heterocycle compound |
12/29/2004 | WO2004112832A2 Immunogenic compositions comprising multiple gonococcal antigens |
12/29/2004 | WO2004048419A9 Method of classifying, purifying and using fenugreek seeds |
12/29/2004 | WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
12/29/2004 | EP1491524A2 Selective androgen receptor modulators and methods of use thereof |
12/29/2004 | EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
12/29/2004 | EP1491207A1 Novel screening method |
12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
12/29/2004 | EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11 |
12/29/2004 | EP1490393A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
12/29/2004 | EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
12/29/2004 | EP1490324A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
12/29/2004 | EP1490121A1 Drug delivery particle |
12/29/2004 | EP1490120A1 Embolization |
12/29/2004 | EP1490081A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
12/29/2004 | EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
12/29/2004 | EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
12/29/2004 | EP1490064A1 Substituted pyridinones as modulators of p38 map kinase |
12/29/2004 | EP1490041A1 Treatment of female sexual dysfunction |
12/29/2004 | EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
12/29/2004 | EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders |
12/29/2004 | EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
12/29/2004 | EP1135123B1 Use of isatin derivatives as ion channel activating agents |
12/29/2004 | EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity |
12/29/2004 | EP0830130B9 Tnf-alpha converting enzyme |
12/29/2004 | EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
12/29/2004 | CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
12/29/2004 | CN1558724A Herbal nutraceutical formulation for females/expectant mothers and its process of preparation |
12/29/2004 | CN1557485A Application of gene recombined human lysozyme in eliminating pathogenic microorganism infection |
12/29/2004 | CN1557477A Sterile and freeze dried hypophysin preparation for injection and its preparing process |
12/29/2004 | CN1557461A Chinese medicinal preparation for treating climacteric metancholia of qi and blood deficiency type and preparing process thereof |
12/29/2004 | CN1557443A 'Fufukang' Chinese traditional medicine preparation and preparing process thereof |
12/29/2004 | CN1557438A Medical capsule for treating pelvic inflammatory disease and its preparing process |
12/29/2004 | CN1557422A Chinese medicinal preparation for treating gynopathy |
12/29/2004 | CN1557412A Chinese medicine composite preparation for treating blood syndrome of woman |
12/29/2004 | CN1557404A Medicine for treating hyperplasia of mammary glands and preparation method thereof |
12/29/2004 | CN1557373A Chinese medicine preparation for treating climacteric metancholia of liver depression and qi stagnation |
12/29/2004 | CN1557372A Chinese medicine preparation for treating climacteric metancholia of liver-yang hyperactive type and its preparing process |
12/29/2004 | CN1557359A Mammary gland lobular hyperplasia treating plaster and its preparing process |
12/29/2004 | CN1557342A Antisenescent and sexual function improving preparation |
12/29/2004 | CN1557333A Chinese traditional medicine composition and its preparation and quality control method thereof |
12/29/2004 | CN1557311A Fibrauretine capsule tablet and its preparation method |
12/29/2004 | CN1557295A Gynecopathy therapeutic drug |
12/29/2004 | CN1557294A Oryzanol containing soft capsule preparation method |
12/29/2004 | CN1557288A Lactic acid , glycerin formulation for female vagina acidity, humidity improvement |
12/29/2004 | CN1181887C Recombinant gamma-interferon for preventing and treating cow's recessive mammitis |
12/29/2004 | CN1181865C Quick dissolving sensitive layer for treating gynecopathy |
12/29/2004 | CN1181824C Minocycline vaginal effervescent tablets |
12/29/2004 | CA2534748A1 Relaxin superfamily peptide analogues |
12/28/2004 | US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
12/28/2004 | US6835751 Bicyclic amino acids as pharmaceutical agents |
12/28/2004 | US6835744 3,3-substituted indoline derivatives |
12/28/2004 | US6835737 Quinoline inhibitors of cGMP phosphodiesterase |
12/28/2004 | US6835716 Bactericides, antiprotozoa agents |
12/28/2004 | US6835388 Mixing a compound which acts as a local anesthetic with physiological salt; placing formulation in a catheter; administering formulation into uterine cavity of woman with a catheter; pertubating the formulation into peritoneal cavity |
12/28/2004 | US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery |
12/23/2004 | WO2004110461A1 Treatment of symptoms associated with bacterial vaginosis |
12/23/2004 | WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST |
12/23/2004 | WO2004094451A3 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES |
12/23/2004 | WO2004071390A3 Piperazine-2-carboxamide derivatives |
12/23/2004 | WO2003089002A9 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia |
12/23/2004 | US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |